Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

World Health Assembly

- PMLiVE

WHO backs use of untested drugs in Ebola

Public health risk means it is ethical to offer treatments with unknown adverse effects

- PMLiVE

US fast-tracks Ebola vaccine trials as outbreak spreads

NIH brings forward human trials as concerns mount

- PMLiVE

WHO raises red flag on hepatitis C drug pricing

Warns about cost of Gilead’s Sovaldi and J&J’s Olysio

- PMLiVE

Treatment alone will not tackle cancer epidemic, says WHO

Burden will be highest in developing countries

- PMLiVE

WHO appoints two regional directors

Dr Poonam Khetrapal Singh and Dr Shin Young-soo to head major areas

- PMLiVE

WHO tells pharma to research drugs for older people

Says industry R&D changes just as important as updating healthcare systems

- PMLiVE

WHO claims $1.3bn annual funding gap for tuberculosis research

Says action needs to be taken now to halt spread of multi-drug resistant TB

- PMLiVE

WHO warns of medicines shortage in Syria

Conflict affecting production and import of essential drugs

- PMLiVE

WHO says people now expect universal health coverage

But director general says nations need to take own path to achieve this goal

- PMLiVE

WHO appoints regional director for the Americas

Dominica’s Dr Carissa Etienne has rich history in healthcare policy

- PMLiVE

Medicine donations helping in battle against tropical diseases

WHO report provides update, one year after pact with big pharma

- PMLiVE

WHO launches framework to monitor non-communicable diseases

Will measure success of efforts to reduce rates of cancer, diabetes, lung conditions and heart disease

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links